Company: CERO
Filing Date: 2025-06-16
Form Type: 424B3
Source: 0001213900-25-054769
Chunk: 9

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-06-16
Form: 424B3
Chunk 9
---
 New risk factors emerge from time to time, and it is not possible to predict all such risk factors,
nor can the Company assess the impact of all such risk factors on its business, or the extent to which any factor or combination of factors
may cause actual results to differ materially from those contained in any forward-looking statements. Forward-looking statements are not
guarantees of performance. You should not put undue reliance on these statements, which speak only as of the date hereof. All forward-looking
statements made by the Company or persons acting on its behalf are expressly qualified in their entirety by the foregoing cautionary statements.
The Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information,
future events or otherwise, except as required by law.

<div align='center'>1

SIGNATURE</div>

Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.

| Dated: June 13, 2025 | CERO THERAPEUTICS HOLDINGS, INC. |                         |
|:---------------------|:---------------------------------|:------------------------|
|                      | By:                              | /s/ Chris Ehrlich       |
|                      | Name:                            | Chris Ehrlich           |
|                      | Title:                           | Chief Executive Officer |

<div align='center'>2</div>